Vaxxa reports sharply increased revenue and a positive operating result in the second quarter."The second quarter shows that Vaxxa has taken the step from strong growth to profitable growth. We report a positive operating result while revenue increased by 57 percent. For a long time, we have built a business where each new deal contributes, which shows that our business model is scalable and works as planned", says CEO Karl Frindberg.Revenue amounted to SEK 29.5 million (18.8).EBITDA amounted to SEK 0.6 million (-1.0). Vaxxa, SEK millionQ2Q2 previous yearChangeRevenue29.518.8+56.5%EBITDA0.6-1.0